Effectiveness of orally administered probiotic Lactobacillus reuteri in patients with peri-implant mucositis: a prospective clinical study


Published: 27 September 2021
Abstract Views: 684
pdf: 422
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • F. Signorino DDS, MSc, Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit, Fondazione IRCSS Cà Granda Maggiore Policlinico Hospital, University of Milan, Milan,, Italy. https://orcid.org/0000-0002-5232-0909
  • N. Z. Nagibi DH, Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit, Fondazione IRCSS Cà Granda Maggiore Policlinico Hospital, University of Milan, Milan,, Italy. https://orcid.org/0000-0003-2343-9975
  • G. Allocca DH, Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit, Fondazione IRCSS Cà Granda Maggiore Policlinico Hospital, University of Milan, Milan,, Italy. https://orcid.org/0000-0002-7762-0473
  • C. Maiorana Full Professor and Chairman. Oral Surgery and Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit - Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit, Fondazione IRCSS Cà Granda Maggiore Policlinico Hospital, University of Milan, Milan, Italy.
  • P. P. Poli DDS, MSc, PhD, Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit, Fondazione IRCSS Cà Granda Maggiore Policlinico Hospital, University of Milan, Milan, Italy. https://orcid.org/0000-0003-3739-1490

Aim The aim of the present prospective clinical study was to evaluate the effectiveness of orally administered probiotic Lactobacillus reuteri in the treatment of peri-implant mucositis.

Materials and methods Eighty patients showing peri-implant mucositis were enrolled and assigned to two different treatment groups. In the test group subjects were instructed to take one probiotic lozenge daily for 30 days. In the control group, patients received placebo. Periodontal indices including plaque index (PI), bleeding on probing (BOP), and probing depth (PD) were clinically recorded around natural teeth and implants at baseline and after a period of 1 month and 3 months.

Results After 3-month evaluation in the test group the differences of plaque and bleeding indices remained statistically significantly lower compared to baseline at both teeth and implants. Contrariwise, no statistically significant differences of PI and BOP were observed in the control group. The intergroup comparison at 3 months yielded statistically significantly lower values for all periodontal parameters around teeth when the probiotic was used. Conversely, no statistically significant differences in periodontal parameters were observed between test and control groups at 3 months around implants.

Conclusions Probiotic intake was effective in reducing PI, BOP, and PD scores around natural teeth and dental implants affected by peri-mucositis, in particular around natural teeth at 3 months.


Signorino, F., Nagibi, N. Z., Allocca, G., Maiorana, C., & Poli, P. P. (2021). Effectiveness of orally administered probiotic Lactobacillus reuteri in patients with peri-implant mucositis: a prospective clinical study . Journal of Osseointegration, 13(3), 144–149. https://doi.org/10.23805/JO.2021.13.03.7

Downloads

Download data is not yet available.

Citations